Overview

Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

Status:
Terminated
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of study drug in improving visual acuity compared to laser treatment in the patients with diabetic macular edema
Phase:
Phase 2
Details
Lead Sponsor:
Quark Pharmaceuticals
Collaborator:
Pfizer